Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Cash from Operations (2016 - 2026)

Iradimed has reported Cash from Operations over the past 14 years, most recently at 8290000.0 for Q1 2026.

  • Quarterly Cash from Operations rose 93.15% to 8290000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 28945000.0 through Mar 2026, up 11.19% year-over-year, with the annual reading at 24947000.0 for FY2025, 2.64% down from the prior year.
  • Cash from Operations was 8290000.0 for Q1 2026 at Iradimed, up from 5922572.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 9115714.0 in Q3 2024 and troughed at 1392684.0 in Q3 2023.
  • The 5-year median for Cash from Operations is 4292000.0 (2025), against an average of 4845219.0.
  • Year-over-year, Cash from Operations plummeted 64.64% in 2023 and then surged 554.54% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 3038844.0 in 2022, then rose by 28.75% to 3912480.0 in 2023, then soared by 53.01% to 5986606.0 in 2024, then decreased by 1.07% to 5922572.0 in 2025, then skyrocketed by 39.97% to 8290000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Cash from Operations are 8290000.0 (Q1 2026), 5922572.0 (Q4 2025), and 6986075.0 (Q3 2025).